Amundi’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-120
Closed -$2.22K 1669
2025
Q1
$2.22K Buy
120
+57
+90% +$850 ﹤0.01% 1952
2024
Q4
$753 Buy
+63
New +$737 ﹤0.01% 2061
2023
Q1
Sell
-1,223,545
Closed -$14.1M 2056
2022
Q4
$14.1M Buy
1,223,545
+14,183
+1% +$173K 0.01% 780
2022
Q3
$14.8M Sell
1,209,362
-73,433
-6% -$1.07M 0.01% 758
2022
Q2
$17.4M Buy
1,282,795
+113,250
+10% +$1.19M 0.01% 653
2022
Q1
$13.2M Sell
1,169,545
-4,863
-0.4% -$43.8K 0.01% 751
2021
Q4
$10.4M Buy
1,174,408
+1,087,508
+1,251% +$19M 0.01% 823
2021
Q3
$1.39M Buy
+86,900
New +$1.68M ﹤0.01% 1245

Other funds holding ALHC

Amundi's ALHC Position: Q2 2025 in Review

Amundi sold out of Alignment Healthcare (ALHC) in Q2 2025, closing a stake of 120 shares — an estimated $2.22K sold.

Amundi first reported a position in ALHC in Q3 2021 and held it in 8 quarters. The position peaked at $17.4M in Q2 2022. 217 funds tracked by Wall St. Rank hold ALHC as of Q2 2025.

  • Amundi reported no remaining Alignment Healthcare position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 120 Alignment Healthcare shares in Q2 2025, an estimated $2.22K.
  • Amundi first reported a position in Alignment Healthcare in Q3 2021 and held it in 8 quarters.
  • Amundi's Alignment Healthcare position peaked at $17.4M in Q2 2022.
  • 217 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.